Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | REN | P00797 | 2/20 | 0.58 |
| ▸ | EED | O75530 | 1/20 | 0.56 |
| ▸ | CTSC | P53634 | 1/20 | 0.56 |
| ▸ | PSMB5 | P28074 | 4/20 | 0.54 |
| ▸ | MME | P08473 | 2/20 | 0.54 |
| ▸ | NTSR2 | O95665 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30052854 | 0.96 | CTSC (0.56) | RENEEDCTSCPSMB5MME | |
| SCHEMBL10364374 | 0.95 | CTSC (0.59) | RENEEDCTSCPSMB5MME | |
| SCHEMBL30974255 | 0.92 | REN (0.56) | RENEEDCTSCPSMB5MME | |
| SCHEMBL30546877 | 0.91 | CTSC (0.63) | RENCTSCPSMB5MME | |
| SCHEMBL29701979 | 0.91 | CTSC (0.63) | RENCTSCPSMB5MME | |
| SCHEMBL29702042 | 0.91 | CTSC (0.63) | RENCTSCPSMB5MME | |
| SCHEMBL29789248 | 0.91 | EED (0.59) | RENEEDNTSR2 | |
| SCHEMBL29607879 | 0.91 | EED (0.59) | RENEEDNTSR2 | |
| SCHEMBL22686941 | 0.90 | REN (0.56) | RENEEDCTSCPSMB5 | |
| SCHEMBL30017540 | 0.90 | REN (0.51) | RENEEDCTSC |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12622975-B2 | Peptide-conjugated prodrugs | BRANDEIS UNIVERSITY (US) | 2026-05-12 | — | — | US | disclosed |
| US-20220387610-A1 | PEPTIDE-CONJUGATED PRODRUGS | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2022-12-08 | — | — | US | disclosed |
| CN-109234295-B | Method for synthesizing fatty alcohol acetate in microorganism body based on fatty acid | 赣南师范大学 | 2022-09-23 | — | — | CN | disclosed |
| CN-109234294-B | Method for synthesizing fatty alcohol acetate in microorganism based on fatty acyl-ACP | 赣南师范大学 | 2022-09-23 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12622975-B2 | Peptide-conjugated prodrugs | PEPD, PAM, VIP | REN 2773/4885EED 2978/4885CTSC 131/4885 |
| US-20220387610-A1 | PEPTIDE-CONJUGATED PRODRUGS | VIP, DNPEP, PEPD | REN 3056/4885EED 4654/4885CTSC 37/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.